Karantanis D - Search Results

1

Oncologic PET/CT interpretation and reporting approaches. Survey in clinical practice.

Karantanis D, Kalkanis D, Allen-Auerbach MS, Herrmann K, Pomykala KL, Bogsrud TV, Lowe VJ, Czernin J. Karantanis D, et al. Nuklearmedizin. 2014;53(2):19-25. doi: 10.3413/Nukmed-0613-13-07. Epub 2014 Jan 29. Nuklearmedizin. 2014. PMID: 24473996

2

Relationship among glycolytic phenotype, grade, and histological subtype in ovarian carcinoma.

Karantanis D, Allen-Auerbach M, Czernin J. Karantanis D, et al. Clin Nucl Med. 2012 Jan;37(1):49-53. doi: 10.1097/RLU.0b013e3182291e03. Clin Nucl Med. 2012. PMID: 22157028

3

Squamous papilloma of the oral cavity and oropharynx on 18F-FDG PET/CT imaging.

Karantanis D, Allen-Auerbach M, Czernin J. Karantanis D, et al. Clin Nucl Med. 2012 May;37(5):e98-9. doi: 10.1097/RLU.0b013e318238f52d. Clin Nucl Med. 2012. PMID: 22475925

4

Oncologic 18F-FDG PET/CT: referring physicians' point of view.

Karantanis D, Kalkanis D, Allen-Auerbach M, Bogsrud TV, Subramaniam RM, Danielson A, Lowe VJ, Czernin J. Karantanis D, et al. J Nucl Med. 2012 Oct;53(10):1499-505. doi: 10.2967/jnumed.111.102228. Epub 2012 Aug 23. J Nucl Med. 2012. PMID: 22917886 Free article.

5

Perceived misinterpretation rates in oncologic 18F-FDG PET/CT studies: a survey of referring physicians.

Karantanis D, Kalkanis D, Czernin J, Herrmann K, Pomykala KL, Bogsrud TV, Subramaniam RM, Lowe VJ, Allen-Auerbach MS. Karantanis D, et al. J Nucl Med. 2014 Dec;55(12):1925-9. doi: 10.2967/jnumed.114.145607. Epub 2014 Nov 7. J Nucl Med. 2014. PMID: 25453041 Free PMC article.

6

18F-FDG PET and PET/CT in Burkitt's lymphoma.

Karantanis D, Durski JM, Lowe VJ, Nathan MA, Mullan BP, Georgiou E, Johnston PB, Wiseman GA. Karantanis D, et al. Eur J Radiol. 2010 Jul;75(1):e68-73. doi: 10.1016/j.ejrad.2009.07.035. Epub 2009 Aug 27. Eur J Radiol. 2010. PMID: 19716248

7

Sources and resources for oncologists to help answer the question: is PET/CT appropriate for my patient?

Karantanis D, Allen-Auerbach M, Czernin J. Karantanis D, et al. Hell J Nucl Med. 2012 Jan-Apr;15(1):2-8. Hell J Nucl Med. 2012. PMID: 22413105

8

The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT.

Bogsrud TV, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Collins DA, Kasperbauer JL, Strome SE, Reading CC, Hay ID, Lowe VJ. Bogsrud TV, et al. Among authors: karantanis d. Nucl Med Commun. 2007 May;28(5):373-81. doi: 10.1097/MNM.0b013e3280964eae. Nucl Med Commun. 2007. PMID: 17414887

9

Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland.

Karantanis D, Bogsrud TV, Wiseman GA, Mullan BP, Subramaniam RM, Nathan MA, Peller PJ, Bahn RS, Lowe VJ. Karantanis D, et al. J Nucl Med. 2007 Jun;48(6):896-901. doi: 10.2967/jnumed.106.039024. Epub 2007 May 15. J Nucl Med. 2007. PMID: 17504869 Free article.

10

18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients.

Karantanis D, O'eill BP, Subramaniam RM, Witte RJ, Mullan BP, Nathan MA, Lowe VJ, Peller PJ, Wiseman GA. Karantanis D, et al. Nucl Med Commun. 2007 Nov;28(11):834-41. doi: 10.1097/MNM.0b013e328264ae7f. Nucl Med Commun. 2007. PMID: 17901765

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page